Here are three to note:
Parsippany-Troy Hills, N.J.-based Allergan elected Adriane Brown to its board of directors. Ms. Brown is the current president and COO of Bellevue, Wash.-based Intellectual Ventures.
Ahead of its stock offering, the FDA approved New York City-based Synergy Pharmaceuticals’ plecanatide. The drug treats chronic idiopathic constipation in adults.
After President Donald Trump demanded pharmaceutical companies offer cheaper drugs, Japan-based Takeda renewed its commitment to its single-digit annual increase pricing model. President Trump would like pharmaceutical companies to lower prices and produce more drugs in the United States.
Takeda’s Chief Executive Christophe Weber said in a results briefing that “Takeda has for many years been reasonable in its price increases in the United States and we are very committed to single-digit price increase [model].”
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Indira Reddy of Wake Endoscopy Center
Can pregnant women undergo endoscopy? 3 study insights
Chemotherapy overused for young, middle-aged adults with colon cancer, no improvement in survival rate: 4 key notes
